informa-healthcare.blogspot.com
Informa Healthcare: Of abstract importance – new abstract style for 2011
http://informa-healthcare.blogspot.com/2010/12/of-abstract-importance-new-abstract.html
Wednesday, 8 December 2010. Of abstract importance – new abstract style for 2011. Series, in 2011 we are requesting authors include the following in their abstracts for review articles:. Describing the significance of the topic and reason for the review. Describing the research discussed and the literature review undertaken. Posted by Anna Treadway. Subscribe to: Post Comments (Atom). Welcome to the New. Top stories and special features. Profiles of our expert authors and editorial board members. Manipul...
informa-healthcare.blogspot.com
Informa Healthcare: September 2010
http://informa-healthcare.blogspot.com/2010_09_01_archive.html
Monday, 27 September 2010. Issue focus "Antibiotics versus resistant bacteria: recent patents". In celebration of 20 years of Expert Opinion on Therapeutic Patents. We are delighted to introduce the October issue. Dr Kirst comments that 20 years of calls for action have slowly been heeded since resistance problems first became widely recognized in the late 1980s and early 1990s prompted by the unexpected appearance of resistance to vancomycin. Posted by Anna Treadway. Expert Opinion on Therapeutic Patents.
informa-healthcare.blogspot.com
Informa Healthcare: June 2010
http://informa-healthcare.blogspot.com/2010_06_01_archive.html
Monday, 28 June 2010. Expert Opinion 2009 Impact Factors. The 2009 ISI Impact Factors (IFs) have just been released, and Expert Opinion has had a good year:. Expert Opinion on Investigational Drugs. Expert Opinion on Therapeutic Targets. Expert Opinion on Biological Therapy. Expert Opinion on Drug Metabolism and Toxicology. Expert Opinion on Drug Safety. Expert Opinion on Emerging Drugs. Expert Opinion on Pharmacotherapy. Expert Opinion on Therapeutic Patents. Expert Opinion on Drug Delivery. 8211; one o...
informa-healthcare.blogspot.com
Informa Healthcare: November 2008
http://informa-healthcare.blogspot.com/2008_11_01_archive.html
Tuesday, 25 November 2008. Challenges facing liposome-based targeted delivery of antithrombotic drugs. Haemorrhage is a major risk factor associated with administration of thrombolytic protein drugs. Can liposome-based thrombolytic preparations reap the full benefits of this delivery system? In the review article entitled “ Liposomes for targeted delivery of antithrombotic drugs. Posted by Beta Win. Thursday, 13 November 2008. Will genomic technologies change the landscape of toxicology research? Will ge...
informa-healthcare.blogspot.com
Informa Healthcare: April 2009
http://informa-healthcare.blogspot.com/2009_04_01_archive.html
Friday, 24 April 2009. Top 5 reasons why medical associations should maintain ties with industry. In the April 1st issue of JAMA, Rothman, et al. spelled out a proposal for controlling conflicts of interest that calls for professional medical associations (PMAs) to cut all ties with industry. PMA conferences, continuing education and practice guidelines often set the standard for patient care. But should a few bad apples be allowed to spoil the bunch? Korn D, Ehringhaus SH. Association of American Me...
informa-healthcare.blogspot.com
Informa Healthcare: January 2010
http://informa-healthcare.blogspot.com/2010_01_01_archive.html
Sunday, 24 January 2010. 10 years of Expert Opinion on Biological Therapy. Expert Opinion on Biological Therapy. Is now in its 10th volume! Posted by Joris Roulleau. Expert Opinion on Biological Therapy. Saturday, 2 January 2010. Celebrating the 20 years of Expert Opinion on Therapeutic Patents. 8220; and “who are the major players in the field? I hope this agenda meets our readers’ expectations and that EOTP will remain, above all, a useful resource to professionals in the field. Posted by Joris Roulleau.
informa-healthcare.blogspot.com
Informa Healthcare: May 2009
http://informa-healthcare.blogspot.com/2009_05_01_archive.html
Tuesday, 12 May 2009. Award winning research at the Dutch Atherosclerosis Symposium, 2009. The years to come are going to be very busy for persons working in the field of atherosclerosis and cardiovascular disease. Basic-science researchers are hot on the trail of targeted drugs that will be much more focused than available drugs, and some remarkable progress is being made. The 12th Dutch Atherosclerosis Symposium. 3 Wijnand den Dekker et al. Molecular Cardiology Laboratory, Erasmus Medical Center Ro...
informa-healthcare.blogspot.com
Informa Healthcare: Special Issue Alert: Transporter-drug interactions and transporter-mediated toxicity in the liver/hepatocyte
http://informa-healthcare.blogspot.com/2010/09/special-issue-alert-transporter-drug.html
Friday, 24 September 2010. Special Issue Alert: Transporter-drug interactions and transporter-mediated toxicity in the liver/hepatocyte. August 2010 Vol. 42, No. 3. Edited by Dr. Laszlo Vereczkey, contains seven articles that may be of interest to people dealing with the structure, regulation, activity, and clinical significance of these proteins. Posted by H.Metherell. Subscribe to: Post Comments (Atom). Welcome to the New. Top stories and special features. Subscribe to the Blog. Expert Opinion on Drug ...
isi-edris.mihanblog.com
دانلود رایگان مقاله آی اس آی درخواستی( Free DOWNLOAD ISI Papers )،بانک و مرجع مقالات علمی و تخصصی، پروژه، دریافت و دانلود رایگان+مجلات و نشریات آی اس آی - Effects of the inner mould material on the aluminium–316L stainless steel explosive clad pipe
http://isi-edris.mihanblog.com/post/8
دانلود رایگان مقاله آی اس آی درخواستی( Free DOWNLOAD ISI Papers )،بانک و مرجع مقالات علمی و تخصصی، پروژه، دریافت و دانلود رایگان مجلات و نشریات آی اس آی. علم و گسترش آسان و ارزان و با کیفیت(هدف ما هموار کردن مسیر پژوهش) Easy, cheap and high quality science and development. فروش نرم افزارهای زیر توسط "سیمرغ سعادت" تضمین می گردد. فروش کتاب های استاندارد"handbook". فروش نرم افزار کلیستر"Callister". فروش نرم افزار MATTER. Kinetic Chains: A Review of the Concept and Its Clinical Applications. مقاله آی اس آی (...
